Humabody Logo (WIPO, 08/12/2021)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark Humabody was filed as Figurative mark on 08/12/2021 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing
| Trademark form | Figurative mark |
| File reference | 1641475 |
| Countries | 
|
| Base trademark |
No. UK00003668766,
July 14, 2021
|
| Application date | August 12, 2021 |
| Expiration date | August 12, 2031 |
Trademark owner
Meditrina Building,
Babraham Research Campus
GB
Babraham Research Campus
GB
Trademark representatives
15 Clare Road
Halifax HX1 2HY
GB
goods and services
01
Chemicals used in industry and science; chemicals for
laboratory research purposes; chemicals for use in medical
research; chemicals for use in oncological research;
antibodies and antibody fragments for scientific and
laboratory use; monoclonal antibodies and antibody fragments
for scientific and laboratory use; antibodies and antibody
fragments for scientific research purposes; antibody
reagents for scientific and laboratory use; antibodies and
antibody fragments for use in medical research; antibodies
and antibody fragments for use in oncological research;
molecules primarily comprised of antibodies and antibody
fragments for use in medical research; molecules primarily
comprised of antibodies and antibody fragments for use in
oncological research; antibodies and antibody fragments for
use in the manufacture of therapeutic products
05
Pharmaceutical and veterinary preparations; therapeutic
preparations for medical and veterinary purposes;
antibodies; antibody fragments; therapeutic preparations
that use monoclonal antibodies; antibodies and antibody
fragments for medical and veterinary diagnostics; antibodies
and antibody fragments for use in the discovery, preclinical
and clinical development of therapeutic products for medical
and veterinary purposes; pharmaceutical preparations in
relation to oncology; antibodies and antibody fragments for
use in oncology and therapeutic treatments in relation
thereto
40
Custom manufacture of chemicals, biologicals, antibodies and
antibody fragments; services for the custom manufacture of
therapies using antibodies and antibody fragments; custom
manufacture of antibody and antibody fragments, for others,
for use in medical therapies, including in relation to
oncology; consultancy, advice and information relating to
all of the aforesaid services
42
Scientific and technological services and research and
design relating thereto; oncological research; laboratory
services relating to antibodies and antibody fragments;
research into the development of antibodies and antibody
fragments; provision of antibodies and antibody fragments
for medical and veterinary research and development;
engineering of antibodies and antibody fragments; scientific
services relating to the discovery, preclinical and clinical
development of therapeutic products; scientific research for
others; research into antibodies, antibody fragments for
others; research into the formation, manufacture, medical
usage and manipulation of antibodies and antibody fragments
for others; consultancy, advice and information relating to
all of the aforesaid services
45
Licensing of research and development; licensing of medical
therapeutic research; licensing of research relating to
antibodies and antibody fragments; licensing of research in
relation to the formation, manufacture, medical usage and
manipulation of antibodies and antibody fragments;
consultancy, advice and information relating to all of the
aforesaid services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 20, 2023 | 2023/31 Gaz | RAW: Holder Rights Restriction | |
| April 6, 2023 | 2023/15 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| December 20, 2022 | 2022/51 Gaz | CH | Rejection |
| November 4, 2022 | 2022/45 Gaz | CN | Rejection |
| November 3, 2022 | 2022/44 Gaz | JP | Rejection |
| June 22, 2022 | 2022/25 Gaz | EM | Rejection |
| June 16, 2022 | 2022/25 Gaz | US | Rejection |
| April 21, 2022 | 2022/16 Gaz | AU | Rejection |
| August 12, 2021 | GB | Registration |
ID: 141641475